D. Delombaerde

Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report

M. Peeters, H. Prenen, C. Vulsteke, 2022, Journal of Medical Case Reports.

POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients

D. Lambrechts, A. González-Neira, G. Pita, 2021, Pharmaceutics.

Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy

H. Prenen, C. Vulsteke, L. Croes, 2021, ESMO open.

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients

T. Powles, C. Vulsteke, L. Croes, 2023, Pharmaceuticals.

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study

J. De Sutter, A. Willems, H. Prenen, 2023, Pharmaceuticals.

The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report

C. Van Steenkiste, B. Defoort, E. Vanderstraeten, 2023, Case Reports in Oncology.

Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors

L. Croes, Veronique Moerman, D. Delombaerde, 2024, Pharmaceuticals.